Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biodesix Q2 EPS $(0.08) Misses $(0.07) Estimate, Sales $20.018M Beat $18.463M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:08pm
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 17.65 percent. This is unchanged from the same period last year. The company reported quarterly sales of $20.018 million which beat the analyst consensus estimate of $18.463 million by 8.42 percent. This is a 11.68 percent increase over sales of $17.925 million the same period last year.

Posted In: BDSX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist